# CoQ10 and Omega-3 as Adjuncts to Periodontal Therapy, TAC of Saliva.

> **NCT06358963** · NA · UNKNOWN · sponsor: **Amirhossein Farahmand** · enrollment: 80 (estimated)

## Conditions studied

- Periodontal Diseases

## Interventions

- **DRUG:** Receive 30 mg of Coq10
- **DRUG:** Non-Medicare Drugs

## Key facts

- **NCT ID:** NCT06358963
- **Lead sponsor:** Amirhossein Farahmand
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-02-20
- **Primary completion:** 2024-04-20
- **Final completion:** 2024-05-10
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2024-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06358963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06358963, "CoQ10 and Omega-3 as Adjuncts to Periodontal Therapy, TAC of Saliva.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06358963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*